life sciences

A Closer Look at the HTI-4 Final Rule

By Mary Griskewicz – At its core, HTI-4 is about making prescribing and medication access more real-time, transparent, and aligned with patient needs. It updates health IT certification criteria in three key areas: electronic prescribing, real-time prescription benefit (RTPB), and electronic prior authorization (ePA).

Read More

ASTP/ONC’s HTI-4 Final Rule

By Tom Keane & Steven Posnack – ASTP/ONC released a final rule enabling the use of certified EHRs to submit prior authorizations, select drugs consistent with a patient’s insurance coverage, and exchange electronic prescription information with pharmacies and insurance plans.


Clinical Calculators in Healthcare and EHRs

By Victoria Mendonca MS MBA & Shane Bell – If you’ve spent any time around clinicians, you’ve probably heard names like CHA₂DS₂-VASc or HAS-BLED thrown around. These are not secret codes but examples of clinical calculators—tools that help healthcare professionals evaluate risks, guide diagnostic decisions, and determine appropriate treatments.


Prescribing Clarity Isn’t Optional

By Amy Johnson – For pharmaceutical manufacturers and life sciences organizations, ensuring patients use medications as intended is central to outcomes, safety, and adherence. But when EHR prescribing workflows introduce ambiguity, especially with patient instructions, those goals become harder to achieve.


Studies, Surveys and Reports: What Can We Learn?

We have rounded up some reports and surveys from around the industry that we thought were of interest from Luna Physical Therapy, Royal Philips, Cognizant, Nordic Consulting Partners, Wolters Kluwer Health, Incredible Health, Physicians for Human Rights, HealthEdge, MedPAC, Accenture, HHAeXchange, and more.



Should Life Sciences Manufacturers Care about FQHCs?

By Amber Glende – If you work in life sciences, whether in pharma, diagnostics, or vaccines, Federally Qualified Health Centers might not be on your radar. Many manufacturers focus their commercial strategies on large health systems, private practices, and specialty networks, leaving FQHCs largely untapped.


Exploring the Future of Genomics and Life Sciences

NOW on Demand This Just In episode with host Justin Barnes and his guests Harini Malik, Worldwide Strategic Business Development Lead: Public Sector, Telco, Healthcare, and Retail from AMD, and Sandra Colner, General Manager for Healthcare and Life Science Alliances at Dell Technologies


AI in Life Sciences Finds an Early Success and Will Continue in 2025

Our annual predictions for 2025 continue with AI in Life Sciences. Throughout the next few weeks we will be asking the industry experts what they think we will see in 2025. Check back as we cover value-based care, interoperability, virtual care, and how AI will impact healthcare finance, security, RCM, and clinical issues.